Results 371 to 380 of about 2,974,682 (398)
Some of the next articles are maybe not open access.

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco   +2 more
exaly  

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel   +2 more
exaly  

Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis

Multiple Sclerosis, 2004
Juan Feng   +12 more
semanticscholar   +1 more source

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo   +2 more
exaly  

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann   +2 more
exaly  

Prevention of Ventricular Fibrillation by Cilostazol, an Oral Phosphodiesterase Inhibitor, in a Patient with Brugada Syndrome

Cardiovascular Electrophysiology, 2002
T. Tsuchiya   +3 more
semanticscholar   +1 more source

Phosphodiesterase 4 inhibitors

Expert Opinion on Therapeutic Patents, 1997
openaire   +2 more sources

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Nature Medicine, 2018
Yuting Sun   +2 more
exaly  

Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1‐ but not type 2‐associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats

European Journal of Immunology, 1993
O. Rott, E. Cash, B. Fleischer
semanticscholar   +1 more source

Phosphodiesterases 4 Inhibitors

1998
Catherine Burnouf   +2 more
openaire   +1 more source
pharmacology
biology
phosphodiesterase inhibitors
erectile dysfunction
sildenafil
endocrinology
cgmp-specific phosphodiesterase type 5
animals
in vitro
previous   36  37  38  39  40  

Home - About - Disclaimer - Privacy